Article Details
Retrieved on: 2021-04-11 12:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... end of 2021, using genetic technology to stimulate the immune system, said Feng Duojia, president of the China Association of Vaccines. ... Walvax Biotechnology and Suzhou Abogen Biosciences, has completed its phase 1 and ...
Article found on: www.ecns.cn
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here